close
close
news

Yankees donate World Series tickets to pediatric patients, ‘The Warriors’ stars die and more

The New York Yankees donated World Series tickets to a childhood cancer patient after fan intervention and David Harris, an actor known for his role as Cochise in “The Warriors,” died of cancer at age 75.

Yankees donate World Series tickets to pediatric patients, ‘The Warriors’ stars die and more

Pediatric patient gifted World Series tickets after fan interference during game 4

A pediatric cancer patient and his family were given tickets by the New York Yankees for Game 5 of the World Series, the team said in a report on mlb.com.

Calvin Young, 15, of New Jersey, received the tickets after two fans who interfered in Game 4 of the series were kicked out of Yankee Stadium and not allowed back for the next game. Their tickets, and others in the same section, were redistributed to Young and his family.

According to the report, Calvin was scheduled to attend the game with his mother and his two brothers, marking the first time either of them had attended a postseason game at the stadium.

During the game, held on October 30, the Yankees lost both the game and the series to the Los Angeles Dodgers.

David Harris of ‘The Warriors’ died of cancer.

David Harris, co-star of the 1979 cult classic “The Warriors,” died Oct. 25 at the age of 75; his daughter, Davina Harris, told the New York Times that cancer was the cause of death.

Harris was known to fans for his work as Cochise, a New York City gang member, in the Walter Hill-directed film. After “The Warriors,” Harris appeared in films such as “A Soldier’s Story” and had guest-starring roles on television series such as “Law and Order,” “ER,” “NYPD Blue” and “Elementary.”

Lin-Manuel Miranda, who recently released a concept album inspired by “The Warriors,” paid tribute to Harris on Instagram.

“Shocked and saddened by the passing of David Harris, also known as the original Cochise on ‘The Warriors,’” Miranda wrote. “We celebrated a little over a week ago and gave him his flowers for his unforgettable performance. Grateful for that moment with him. Our hearts are with his daughter and a host of family and friends.”

“Frasier” Star underwent treatment for breast cancer

Toks Olagundoye, who stars as Professor Olivia Finch in the Paramount+ revival of “Frasier,” revealed that she underwent treatment for breast cancer during production of the show’s first season.

Olagundoye, who appeared on ‘The Kelly Clarkson Show’, stated that she was diagnosed with stage 0 triple-negative breast cancer at the age of 46, and that the disease had progressed to stage 1 by the time she was told she would need treatment had to undergo. operation, a report said Variety. She underwent three surgeries and chemotherapy before the series began filming, and underwent a double mastectomy midway through production after filming three episodes. Variety reported.

Her health problems put her job in jeopardy until she received a call from series star Kelsey Grammer.

“He was very emotional, he didn’t realize what I was going through, and he said, ‘I know how actors think, I want you to know that this is your family, you’re not going to get fired, we’re going to do what we have to do to making sure you feel comfortable,” she told Clarkson. “I remember him saying so vividly, ‘You’ll be so happy after this. Everything will be fine. ”

The ‘Frasier’ revival premiered on Paramount+ in October 2023, followed by a second season in September 2024.

About triple-negative breast cancer

Triple-negative breast cancer is an aggressive form of invasive breast cancer that tends to grow and spread more quickly, has fewer treatment options and often has a poorer prognosis.

The term triple negative refers to the fact that the cancer cells have no estrogen or progesterone receptors and do not produce any or too much of the HER2 protein.

About 10% to 15% of breast cancer cases are triple negative and often occur in women under age 40 who are black and have a BRCA1 mutation.

Source: American Cancer Society

For more cancer updates, research and education, subscribe to CURE® newsletters here.

Related Articles

Back to top button